Sri G Yarlagadda MD

Associate Professor, Internal Medicine, University of Kansas School of Medicine

3901 Rainbow Blvd# StopKansas City, KS 66160
Phone+1 913-588-6074
Fax+1 913-588-3867

Dr. Yarlagadda is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yarlagadda's full profile Already have an account?

Summary

Dr. Sri Yarlagadda is a nephrologist located in Kansas City, KS. She completed her residency in Internal Medicine at the University of Connecticut and her Nephrology fellowship at Yale-New Haven Medical Center. Currently, she is serving as a Nephrologist at The University of Kansas Hospital. Her expertise lies in general nephrology, dialysis, and hereditary kidney disease. Dr. Yarlagadda has published several works in reputed journals, with notable topics such as hypertensive crisis in kidney disease patients and Fanconi Syndrome. She has been honored with multiple awards including the Young Investigator Award from the American Society of Hypertension-Eastern Chapter and the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR.

Education & Training

Yale-New Haven Medical CenterFellowship, Nephrology, 2005 - 2008
University of ConnecticutResidency, Internal Medicine, 2002 - 2004
St Barnabas HospitalInternship, Internal Medicine, 2001 - 2002
M. Rampure Medical CollegeClass of 2000

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

KS State Medical License 2008 - 2027
MO State Medical License 2021 - 2027
CT State Medical License 2007 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017

Publications & Presentations

PubMed

Pulmonary Embolism in Patients with End-Stage Kidney Disease Starting Dialysis.
Kunal N Patel, Wan-Chi Chan, Vivek Bhat, Monil M Majmundar, Harsh Mehta
JAMA Network Open. 2025-03-03
2 citations
Nationwide trends and outcomes of percutaneous coronary intervention for stable ischemic heart disease in end-stage kidney disease: a longitudinal study.
Rhythm Vasudeva, Harsh Mehta, Wan-Chi Chan, Sania Jiwani, Sri G Yarlagadda
Annals of Translational Medicine. 2024-12-24
Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant.
Sania Jiwani, Wan-Chi Chan, Monil Majmundar, Kunal N Patel, Harsh Mehta
Vascular Medicine. 2024-04-01

Journal Articles

Metastatic Calcifications after parathyroidectomy in a dialysis patient
Munis Mattu and Sri G Yarlagadda, Nephrology, 1/1/2013
First Case of Donor Transmitted Non Leukemic Promyelocytic Sarcoma
Williams T, Aljitawi OS, Moussa R, McHugh S, Dusing R, Abraha J, Yarlagadda SG, Leuk Lymphoma, 1/9/2012
Blood group A isoagglutinins in A2-> O simultaneous liver/kidney transplantation may not influence kidney function
Bryan CF, Abdulkarim A, Nawabi A, Stewart A, and Yarlagadda SG, American Journal of Transplantation, 1/1/2011

Abstracts/Posters

The influence of HLA Class 2 donor specific antibodies present at the time of renal transplantation on Early Graft Outcome
Christopher Bryan, Aditi Gupta, Daniel Murillo, Connie Wang, Sri G Yarlagadda, Atta Nanwabi, Timothy Schmitt, American Transplant Congress, 1/1/2013
Urinary Cystatin C and KIM-1: A Tale of Two Novel Biomarkers of Acute Kidney Injury in Predicting the Need for Dialysis after Kidney Transplantation
Sri G. Yarlagadda, American Transplant Congress Meeting, 1/1/2009
Urine NGAL and IL-18 are better markers of DGF compared to existing parameters.
Sri G. Yarlagadda, American Society of Nephrology Meeting, 1/7/2008

Other

Effect of diuretics on magnesium handling by the kidney.
Alan S L Yu, Sri G Yarlagadda, UpToDate
1/1/2013
Clinical Manifestations of magnesium depletion.
Alan S L Yu, Sri G Yarlagadda, UpToDate
1/1/2013
Parathyroid and Mineral Metabolism after renal transplantation.
Sri G Yarlagadda, David W Butterly, L Darryl Quarles, UpToDate
1/1/2009